Funding Rounds
Corteria Pharmaceuticals

Corteria Pharmaceuticals Series A (2023, $69M)

Corteria Pharmaceuticals

Interceptive therapies for heart failure subpopulations.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $69.61M

Raised Date: 2023-07-01

Investors